Cargando…
Everolimus with or without mycophenolate mofetil in a liver transplantation setting: a single-center experience
BACKGROUND: This study evaluated the efficacy, safety, and impact on renal function of everolimus in patients after liver transplantation (LT) with or without mycophenolate mofetil (MMF). METHODS: We evaluated LT recipients with calcineurin inhibitor (CNI)-related renal dysfunction after everolimus...
Autores principales: | Cholongitas, Εvangelos, Goulis, Ioannis, Theocharidou, Eleni, Antoniadis, Nikolaos, Fouzas, Ioannis, Imvrios, George, Giouleme, Olga, Angelaki, Aliki, Vasiliadis, Themistoklis, Papanikolaou, Vasilios, Akriviadis, Evangelos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102469/ https://www.ncbi.nlm.nih.gov/pubmed/30174399 http://dx.doi.org/10.20524/aog.2018.0278 |
Ejemplares similares
-
Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels
por: Sinakos, Emmanouil, et al.
Publicado: (2016) -
Everolimus/mycophenolate-mofetil: COVID-19 pneumonia: case report
Publicado: (2021) -
The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis
por: Cholongitas, Evangelos, et al.
Publicado: (2015) -
Hepatopulmonary syndrome is associated with the presence of hepatocellular carcinoma in patients with decompensated cirrhosis
por: Soulaidopoulos, Stergios, et al.
Publicado: (2017) -
Influence of cyclosporine and everolimus on the main mycophenolate mofetil pharmacokinetic parameters: Cross-sectional study
por: Noreikaitė, Aurelija, et al.
Publicado: (2017)